Skip to main content
. Author manuscript; available in PMC: 2012 May 17.
Published in final edited form as: J Am Chem Soc. 2011 Jul 21;133(32):12834–12841. doi: 10.1021/ja204969m

Figure 4.

Figure 4

Spiroadamantane inhibitor 9 design and its dose response curve on WT, V27A, L26F and S31N inhibition. (a) Structure-based design of spiroadamantane 9. (b) X-ray crystal structure of spiroadamantane 9. (c) Dose response curve of 9 against WT, V27A and S31N A/M2 inhibition.